Daresbury Proteins Ltd.

Daresbury Proteins Ltd, based in Warrington, UK, is a small, active company founded seven years ago in 2017. It employs three people and holds £112,490 in assets. This family business, managed by four directors and two owners, operates from a real address and is in the process of expanding. It’s an irregular importer, primarily bringing in miscellaneous metal items, with the last import occurring one month ago.

The company specializes in mammalian recombinant protein production and cell line development, offering services to academic and industrial partners. Its website highlights a novel expression platform and aims to support clients in rapidly assessing the functionality of their candidates while reducing costs and risks. They’re even licensed their background IP to Thermo Fisher Scientific, USA.

Financially, Daresbury Proteins Ltd shows a mixed picture. Cash reserves increased by 54% to £92,000, while current assets rose by 37% to £110,000. However, net assets decreased significantly by 410% to -£150,000. Bank borrowings have also fluctuated, with current borrowings remaining steady at £600 but long-term borrowings decreasing by 53%. Creditors increased by 60%, and the company’s equity is now negative. The company meets two of three conditions to be considered small, with a turnover under £10.2 million and assets under £5.1 million. The lack of an auditor is typical for a small company.

The company’s financial trajectory suggests it’s burning through cash, despite increased assets. This could be due to investment in growth, or it could signal underlying challenges. The company's focus on high-value protein production and its licensing agreement with Thermo Fisher Scientific offer potential for future success, but the negative equity is something to keep an eye on.

Registered in England/Wales under the registration number 10835544, with a registered address at WA4 4AD, England, Warrington, Itac-Bio 19 Sci-Tech Daresbury, Keckwick Lane.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.